RxDoctor Payments Data

Kevin Yip, MD

Rheumatology · Brooklyn, NYNPI 1073034666

Payments from drug & device makers

$3,782in general payments, 2019–2025

Across 37 payments — averaging $102.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sobi, Inc$2K
  • AbbVie$462
  • Amgen$223
  • GSK$184
  • Boehringer Ingelheim$121
  • Johnson & Johnson$101
  • plus $215 from 7 others

What the payments were for

  • Consulting fees$2,14057%
  • Food & beverage$1,64243%

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sobi, Inc4$2,476
AbbVie11$462
Amgen(2 entities)2$223
GSK4$184
Boehringer Ingelheim4$121
Johnson & Johnson(2 entities)4$101
Novartis2$56
UCB, Inc.1$37
Pfizer1$30
Exact Sciences1$27
Teva Pharmaceuticals USA, Inc.1$23
Shionogi Inc1$22
Merck1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,782 in reported general payments places this provider in the 55th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York

Medicare billing

Part B allowed, 2024
$12,087
Medicare patients
34
Services billed
84

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxychloroquine Sulfate11$579
MethotrexateMethotrexate Sodium15$571
Prednisone36$123

Paid to pharmacies, not to this prescriber.

Other rheumatology in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →